TB-500 (Thymosin Beta-4 fragment) is a synthetic peptide that has gained popularity in regenerative medicine, biohacking, and athletic recovery circles for its potential to support tissue repair, reduce inflammation, and improve flexibility.
It is a shortened, synthetic version of Thymosin Beta-4 (TB4), a naturally occurring 43-amino-acid protein found in nearly all human cells (especially platelets and wound fluid). TB-500 typically refers to the active fragment (often Ac-LKKTETQ) that mimics some of TB4’s effects on actin regulation.
How TB-500 Works
TB-500 primarily influences actin, a key protein for cell structure and movement:
- It sequesters G-actin monomers, making them available for cell migration and tissue remodeling.
- This promotes angiogenesis (new blood vessel formation), cell proliferation, migration, and reduced inflammation.
- In animal models, it accelerates wound healing, supports muscle/tendon/ligament repair, and aids recovery from injuries.
It is often stacked with BPC-157 (the “Wolverine Stack”) for localized + systemic healing effects. BPC-157 is more gut- and site-specific, while TB-500 acts more systemically.
Potential Benefits (Mostly Preclinical/Anecdotal)
- Tissue repair — Faster healing of muscles, tendons, ligaments, and wounds.
- Reduced inflammation and improved flexibility/mobility.
- Cardiovascular and neuroprotective effects in some studies (e.g., heart repair post-injury, potential brain protection).
- Hair growth and angiogenesis support in limited research.
- Users report quicker recovery from chronic injuries, surgery, or overuse.
Note: Most strong evidence comes from animal studies on full Thymosin Beta-4. Human data on the TB-500 fragment is limited, with no large-scale clinical trials confirming efficacy or long-term safety.
Common Usage & Dosage (Research/Off-Label Protocols)
These are not medical recommendations—consult a qualified healthcare provider. TB-500 is typically sold as a research chemical and injected subcutaneously.
- Loading phase — 2–5 mg twice per week (e.g., 4–10 mg total weekly) for 4–6 weeks.
- Maintenance — 2–5 mg per week or 2–6 mg monthly.
- Often reconstituted with bacteriostatic water and dosed via insulin syringe.
Cycles vary; some use it for 4–8 weeks followed by breaks.
Side Effects & Safety Concerns
Reported side effects are usually mild and transient:
- Injection site reactions (redness, swelling).
- Fatigue, lethargy, or head rush.
- Headache, dizziness, or nausea.
Serious caveats:
- Very limited human clinical trials specifically on TB-500.
- Full Thymosin Beta-4 had mixed results in trials and was not fully approved.
- Potential unknown risks (e.g., angiogenesis could theoretically promote tumor growth in some contexts, though evidence is inconclusive).
- Sold unregulated online—purity and sourcing vary widely.
It is banned in many sports (WADA/prohibited) due to performance-enhancing potential.
Bottom Line
TB-500 shows exciting promise in preclinical research for healing and recovery, especially when combined with BPC-157. Many athletes and biohackers report positive anecdotal results for stubborn injuries. However, it remains experimental with significant gaps in human safety and efficacy data.
Always prioritize evidence-based approaches (physical therapy, nutrition, sleep, medical care) and consult a doctor before considering any peptide. Research chemicals carry legal and health risks depending on your location.
Available here